NOVAVAX Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus
August 20, 2009 by Medical Dude
Filed under Swine Flu
Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax’s 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1vaccine in ferrets. The ferret model [...]
Loading ...